LinkedIn
  • Home
  • Events
  • Networks
  • Awards
  • Publishing
  • About SCS
  • Login/Logout SCS Membership

MipTec 2014: Peptide Therapeutics Forum, Spt 23, 2014

140915 Icon MipTec2Tuesday, September 23, 2014   
Congress Center Basel, Room 5

The Peptide Therapeutics Forum 2014 will be divided up in a morning session on “Peptide Discovery” and afternoon presentations on “Development of therapeutic Peptides”. The first part provides some insight into latest methodologies for peptide synthesis and interesting projects more from a preclinical perspective. The afternoon session is dedicated to more advanced peptides. Topics to be discussed include intracellular delivery of peptides, diagnostic imaging and specific disease associated themes, e.g. peptides from the Incretin family to treat diabetes & obesity. This event is thought to disseminate information on latest developments in the broad field of therapeutic peptides and to enable networking of interested parties from academia and industries.

Organizers: Thomas Vorherr, Eric Kitas

Link to the forum website.

Flyer Peptide Therapeutics Forum, Spt 23, 2014

Link to the Interactive Planner
Please subscribe to our Newsletter so stay informed about the latest updates.

 


David Spichiger, SCS
05.09.2014

 

Prof. Karl-Heinz Altmann awarded the Paul Ehrlich Prize 2014


"The French Medicinal Chemistry Society (SCT) and Janssen-Cilag S.A. are very pleased to annonce that the Paul Ehrlich Prize 2014 is attributed to Professor Karl-Heinz ALTMANN (Institut of Pharmaceutical Sciences, ETH Zürich, Switzerland) recognizing his outstanding  contribution  and substantial  results in the field of the chemistry and chemical biology of pharmaceutically relevant natural products and analogs.  

Professor Altmann will deliver a plenary lecture at the 50th International Conference on Medicinal Chemistry (RICT 2014) in Rouen, Normandy, on July 2-4 2014.

For more information on RICT 2014, see: www.sct-asso.fr



140619 AltmannThe Swiss Chemical Society thanks Prof. Altmann for his outstanding, scientific contributions and contratulates on this honorable award.
Karl-Heinz Altmann is a Member of the SCS divisional board of Medicinal Chemistry & Chemical Biology and was its President from 2011 - 2013.

Website of Prof. Karl-Heinz Altmann, Inst. f. Pharmazeutische Wiss. ,ETH Zürich

 


David Spichiger, SCS
19.06.2014

 

Preview: 3rd Japanese-Swiss Chemical Biology Symposium

140612 Header SJCBS-2014

3rd Japanese-Swiss Chemical Biology Symposium

University of Berne, Departmen of Chemistry and Biochemistry
Freiestrasse 3, 3012 Bern, Lecture Room EG16

Thu, October 2, 2014, 10:15 - Fri October 3, 2014, 17:30


Topics of the Symposium:

- Drug Design
- Peptides and Foldamers
- Nucleic Acids
- Imaging
- Biological Membranes
- Natural Products


Contact (Scientific Committee)

  • Jean-Louis Reymond (University of Bern, Chair)
  • Tamis Darbre (University of Bern)


More information

Website: http://www.sjchembio2014.unibe.ch

 

 


David Spichiger, SCS
12.06.2014

 

Mini Symposium: Kinetics and Thermodynamics in Drug Discovery: May 22, 2014

140307 Banner DMCCB MiniSymposium2014-klein


Mini-Symposium
«Kinetics and Thermodynamics in Drug Discovery»

Thursday, May 22, 2014, 13:30 - 17:45

Big Lecture Hall, Department of Chemistry
University of Basel, 
St. Johanns-Ring 19 


This year's annual mini-symposium organized by the Division of Medicinal Chemistry & Chemical Biology of the Swiss Chemical Society is dedicated to the topic of Kinetics and Thermodynamics in Drug Discovery.

This free event is gathering five globally renowed experts in the field that will showcase the importance of this topic in drug discovery.


Program

13.30h Introduction
13.35h Gerhard Klebe, University of Marburg
Correlation of structure, thermodynamics and molecular
dynamics to better understand drug binding
14.20h  David Swinney, Institute for Rare and Neglected Diseases Drug Discovery
Application of binding kinetics to drug discovery
15.05h  Coffee Break
15.30h  Göran Dahl, AstraZeneca 
Pharmacokinetics and the drug-target residence time concept
16.15h  David Sykes, Novartis Institutes for Biomedical Research
Exploring the relationship between β2-adrenoceptor drug binding affinity/kinetic constants and physicochemical parameters 
17.00  Russel Petter, Celgene
Design and optimization of targeted covalent inhibitors


Poster

Poster DMCCB Mini Symposium 2014


Contact

Nikolaus Stiefl
Novartis Pharma AG
Forum1, Novartis Campus
4056 Basel
Email:


Registration

No registration – free admission
 

Sponsors

Logo Actelion Logo Novartis Logo Polyphor Logo Roche

 

 


David Spichiger, SCS
07.03.2014

Kinetics and Thermodynamics in Drug Discovery: May 22, 2014


Big Lecture Hall, Department of Chemistry
University of Basel, St. Johanns-Ring 19

May 22, 2014, 13.30-17.45 


This year's annual mini-symposium organized by the Division of Medicinal Chemistry & Chemical Biology of the Swiss Chemical Society is dedicated to the topic of Kinetics and Thermodynamics in Drug Discovery.

This free event is gathering five globally renowed experts in the field that will showcase the importance of this topic in drug discovery.

Program

13:30–13:35 Introduction
13:35–14:20


Gerhard Klebe, University of Marburg 
Correlation of Structure, Thermodynamics and Molecular Dynamics to Better Understand Drug Binding
14:20–15:05

David Swinney, iRND3
Application of binding kinetics to drug discovery
15:05–15:30 Coffee Break
15:30–16:15

Göran Dahl, AstraZeneca
Pharmacokinetics and the drug-target residence time concept
16:15–17:00


David Sykes, Novartis Institutes for Biomedical Research
Exploring the relationship betweenb2 adrenoceptor drug binding affinity/kinetic constants and physicochemical parameters
17:00–17:45

Russel Petter, Celgene
Design and Optimization of Targeted Covalent Inhibitors

 
Contact           

Herr Dr. Nikolaus Stiefl
Novartis Pharma AG
Forum1, Novartis Campus
4056 Basel

 


David Spichiger, SCS
03.02.2014

 

  1. Call for nominations: EFMC 2014 Awards
  2. Conferences in Dubai 2014. Discount for SCS Members
  3. Application for the International BioChamp 2012
  4. EFMC: 6th short course on medicinal chemistry.

Page 275 of 298

  • 270
  • 271
  • 272
  • 273
  • 274
  • 275
  • 276
  • 277
  • 278
  • 279

SCS Partners

Image

Contact

Swiss Chemical Society
Haus der Akademien
Laupenstrasse 7
3008 Bern
+41 31 306 92 92
www.scg.ch

About the SCS

About Us and Contacts
Divisions
Networks
SCS Foundation

How to find us (map)

Services

Membership
mySCS / Newsletters




Data Protection and Legal Notice
© Swiss Chemical Society 2023

Login
  • Forgot your password?
  • Forgot your username?
  • Create an account